Clinical trial
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With…
NCT00175045 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00175045 |
|---|---|
| Title | Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis |
| Official title | A Phase 2, Open-Label Multicenter Study to Evaluate the Pharmacodynamics of Intravenous Lansoprazole to That of Oral Lansoprazole in Subjects With Erosive Esophagitis |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophagitis, Reflux |
| Intervention type | Drug |
| Interventions | Lansoprazole |
| Enrollment | 68 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 21, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: